REDD1 inhibits cancer initiation and progression, as evidenced by an increase in tumorigenesis, tumor growth, and metastasis of immortalized Redd1-deficient cells or Redd1-knockdown KrasG12D/+ pancreatic neoplasms in mouse models15,17,150. This evidence concerns the gene DDIT4 and pancreatic neoplasm.